-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/YSj5xRQc9DroH8gpUYsoFA
December 01, 2007 - maintenance of comparable groups, important differential
loss to follow-up or overall high loss to follow-up, measure … One meta-analysis noted that the measure-
ment properties used among ultrasonography laboratories
varied … The primary perioperative complica-
tion measure in the studies was either death/stroke or
death/stroke
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/_cRbjtBvRYVLgT-9_c2jm7
Screening for Skin Cancer
Figure. Screening for Obesity in Children and Adolescents: Clinical Summary
Population Children and adolescents 6 y and older
Recommendation
Screen for obesity; offer or refer children and adolescents with obesity to comprehensive, intensive behavioral
interventions to promot…
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary27/breast-cancer-medications-for-risk-reduction-2013
April 15, 2013 - Limitation: Data on mortality and adherence measures and for women who are nonwhite, are premenopausal … We developed selection criteria for studies based on the patient populations, interventions, outcome measures … Discriminatory accuracy is a measure of how well the model can correctly classify persons at higher risk … We also abstracted model calibration, a measure of how well predicted probabilities agree with actual … Measures of adherence and persistence in clinical trials may not be similar for patients in clinical
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/ovarian-cancer-screening
February 13, 2018 - Main Outcomes and Measures: Ovarian cancer mortality, false-positive screening results and surgery, … adequate randomization procedures and allocation concealment, blinded outcome assessment, reliable outcome measures
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/sharedba.pdf
January 01, 2004 - The measure of an informed and
joint decision, however, should not vary (Figure 2).
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/s9Hht_QpMB4gQg26rTpcaN
November 01, 2013 - 6
6
6
5
6
3
6
6
3
6
6
6
12
6
6
4
6
3
6
6
6
6
6
6
Analyzed, n Follow-up, mo
Weights … 1601
24/202
8/156
21/126
26/201
20/284
6/152
17/216
4/129
12/144
138/1610
Control
Events, n/N
Weights … 105
184
111
131
171
171
56
120
191
74
220
82
93
79
25
96
153
69
99
Analyzed, n
Weights … 60
81
94
132
121
111
195
130
271
221
25
95
96
74
99
157
153
192
155
Analyzed, n
Weights … The IQCODE versus a single-item informant measure to dis-
criminate between cognitively intact individuals
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/aHpXYasjc3n6zhaTtoWMwK
August 01, 2016 - MAIN OUTCOMES AND MEASURES Accuracy of screening tests, benefits of screening, harms of
screening, reduction … Eli-
gible outcomes included reduced rates of symptomatic episodes
and transmission (including measures … For KQ4
(effects of antiviral medication on subclinical HSV-2 shedding),
we included any outcome measure … with no known history of
genital herpes
Studies are uncontrolled;
due to study design and
outcome measures
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/dCH2CMqVyAzf4eyj-ch6H3
August 09, 2016 - MAIN OUTCOMES AND MEASURES Myocardial infarction and ischemic stroke in adulthood;
lipid concentrations … Outcomes
No direct evidence supports a link between lipid concentrations or
measures of atherosclerosis … .65,66 Reaching agree-
ment on acceptable surrogate end points, such as CIMT and other
atherosclerosis measures
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary5/visual-impairment-in-children-ages-1-5-screening-2011
January 15, 2011 - No trial evaluated the effects of treatment on school performance or other measures of function. … No trial evaluated effects of treatment compared with no treatment on school performance or other measures … 22%); mixed anisometropia and strabismus 34/97 (35%)
Fair
a Converted from Snellen metric measures
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/7ZSKduUYHWKe7q_tTY9xbF
April 01, 2013 - Limitation: Data on mortality and adherence measures and for
women who are nonwhite, are premenopausal … developed selection criteria for studies based on
the patient populations, interventions, outcome measures … Discriminatory accuracy is a measure of how well
the model can correctly classify persons at higher risk … We also abstracted
model calibration, a measure of how well predicted prob-
abilities agree with actual … Measures of ad-
herence and persistence in clinical trials may not be similar
for patients in clinical
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication-september-2014
September 09, 2014 - preeclampsia, such as serum biomarkers, uterine artery Doppler ultrasonography, and clinical history and measures … Clinical measures, such as uterine artery Doppler ultrasonography, are not included.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/family-violence-screening-interventions-1996
January 01, 1996 - screening protocols significantly improves the detection of abuse as a cause of trauma, 54 and similar measures … health examination, but recommended that physicians be alert for indicators of abuse and institute measures
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/5UgQm-zskVEKmcVnczHxGY
July 01, 2012 - However, most individual measures were
statistically insignificant, and overall it was difficult to de … However,
these 4 studies used only crude measures of sunscreen use
and did not adjust for sun exposure
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary11/carotid-artery-stenosis-screening-december-2007
December 15, 2007 - between 1994 and 2000 on harms of carotid endarterectomy. 48 The primary perioperative complication measure
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/PGYTn_cWQnmAr9-3du5StE
February 01, 2016 - Outcome and Risk Factor Measures
Outcome measures included rates of false-positive
and false-negative … Two measures of time since the last mammography
screening were evaluated to represent broad and nar- … Our goal was to provide overall rates of the out-
come measures by time since the last mammography
Table … Rates of Missing Data for Outcome and
Risk Factor Measures for 405 191 Women Screened*
Variable Women
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening-1996
January 01, 1996 - ranges. 28 , 29 Current evidence is inadequate to determine the relative superiority of any of these measures … reports without internal controls, usually involving carefully selected patients and surrogate outcome measures
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/Harris2001.pdf
January 01, 2001 - 5 for interme-
diate or health outcomes, respectively), and the associ-
ation between intermediate measures … measured by a DNA probe) are often
used in studies as indicators of efficacy; health out-
comes are measures … Beware of surrogate outcome
measures. Int J Tech Assess Health Care 1996;12:238–46.
20.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/gXnmnkofo8FxoLnCmXJDjb
October 01, 2009 - The 5 studies rated as fair quality were primarily
limited by their use of proxy measures to control … Predictive value of noninvasive measures of atherosclerosis for
incident myocardial infarction: the Rotterdam
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/8JYDupJfG6LdRn7A6FkqXX
March 01, 2016 - .18 Another trial reported no
effect on falls or fracture risk.19 Some studies showed improvements
in measures … function and quality of life associated with cataract sur-
gery, while others reported no effect on these measures
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/drug-use-illicit-primary-care-interventions-for-children-and-adolescents-march-2014
March 11, 2014 - Research to develop and validate tools to measure current and past substance use is needed. … The studies used an unusual and difficult-to-interpret measure of drug use.